Cantitate/Preț
Produs

Moderate to Severe Psoriasis

Editat de John Koo, Jashin Wu, Alice Gottlieb, Ethan Levin, Argentina Leon
en Limba Engleză Hardback – 18 mar 2014
Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.
Citește tot Restrânge

Preț: 91011 lei

Preț vechi: 110791 lei
-18% Nou

Puncte Express: 1365

Preț estimativ în valută:
17418 18373$ 14557£

Carte tipărită la comandă

Livrare economică 01-15 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781482215168
ISBN-10: 1482215160
Pagini: 420
Ilustrații: 56 black & white illustrations, 80 black & white tables, 41 colour tables
Dimensiuni: 178 x 254 x 31 mm
Greutate: 0.94 kg
Ediția:Revised
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States

Public țintă

Professional Reference

Cuprins

An Overview of Psoriasis. Evaluating Psoriasis in Patients. Topical Agents in the Treatment of Moderate to Severe Psoriasis. The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe PSO. Systemic and Topical PUVA Therapy. Therapy of Moderate-To-Severe PSO with MTX. Systemic Retinoids. Cyclosporine in the treatment of severe PSO. Combination, Rotational, and Sequential Therapies. Pediatric Psoriasis, Maya Debbaneh. Psoriatic Arthritis. Etanercept for Treatment of Psoriasis. Adalimumab in the Treatment of Psoriasis. Infliximab in the treatment of PSO. New Agents: IL-17, JAK Kinase. Ustekinumab. Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of PSO. The Immunomodulatory/Immunosuppressive Classification System. Goeckerman and Ingram Day Treatment Program.

Notă biografică

John Koo, Jashin Wu, Alice Gottlieb, Ethan Levin, Argnetina Leon

Descriere

Written by experts in the dermatology field, this new fourth edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and other pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. Illustrated with high quality color figures, this standalone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to this edition are chapters on day treatment programs, new agents, erythrodermic and pustular psoriasis, special populations, and pharmacogenetics.